Santiesteban-Freixas R, Rodríguez-Hernández M, Mendoza-Santiesteban C E, Carrero-Salgado M, Francisco-Plasencia M, Méndez-Larramendi I, Vidal-Casalís S, Rivero-Reyes R, Hirano M
Servicio de Neuroftalmología, Hospital Pando Ferrer, La Habana, Cuba.
Rev Neurol. 1999;29(5):408-15.
Leber's hereditary optic neuropathy (LHON) is a mitochondrial disorder, confirmed at a molecular level 10 years ago. This had permitted better understanding of the condition. Since 1998, the Instituto de Neurología y Neurocirugía has used these techniques for the study of mutations which are considered to be the origin of the disorder.
We describe the characteristics of 14 cases from 10 families with LHON and the molecular confirmation found between 1994 and 1998 in the Instituto de Neurología Neurocirugía de Cuba. We also review the few cases seen in the previous 18 years. These were from only two families. They were diagnosed on clinical grounds and in view of maternal inheritance.
In 80% of the families in which the presence of primary mutations was investigated there was A117789, and in 20% A3460G. The average age of appearance was 28 years. The ages of onset were within the limits of 11 years and 48 years. There were 43% women. Two cases were considered to be sporadic. The clinical features corresponded to those described in such cases, with severe visual defects, central scotomas, very reduced colour vision and severely altered visual evoked potentials, with normal diffuse light and pattern electroretinograms. An improvement in visual acuity of 0.2 was seen in two cases. Microangiopathy, described as characteristic of the early stages of this disorder was detected in five cases, in at least one eye. The others had different degrees of optic atrophy. Two generations of one complete family, all with mutation 3460, were studied. In several families with this mutation alterations were found in the colour vision test of Farnsworth Munsell Hue 100 and also microangiospathy of the retina.
莱伯遗传性视神经病变(LHON)是一种线粒体疾病,于10年前在分子水平得到证实。这使得人们对该病有了更好的理解。自1998年以来,神经学与神经外科学研究所一直使用这些技术研究被认为是该疾病起源的突变。
我们描述了来自古巴神经学与神经外科学研究所1994年至1998年间确诊的10个家庭的14例LHON患者的特征以及分子确诊情况。我们还回顾了此前18年中仅来自两个家庭的少数病例。这些病例是根据临床症状并鉴于母系遗传而确诊的。
在对存在原发性突变的家庭进行调查中,80%的家庭存在A11778G突变,20%的家庭存在A3460G突变。发病平均年龄为28岁。发病年龄在11岁至48岁之间。女性占43%。有2例被认为是散发病例。临床特征与此类病例中所描述的相符,有严重的视力缺陷、中心暗点、严重减退的色觉以及严重异常的视觉诱发电位,而弥漫光和图形视网膜电图正常。有2例患者视力提高了0.2。在5例患者中至少一只眼睛检测到了被描述为此病早期特征的微血管病变。其他患者有不同程度的视神经萎缩。对一个完整家庭的两代人进行了研究,他们均有3460突变。在几个有此突变的家庭中,发现法恩斯沃思-芒塞尔色相100色觉测试有改变,视网膜也有微血管病变。